BHVN

Beyond's analysis on BHVN

• 2026-09-12 — SueWallSt alert triggers ~15% drop in Biohaven shares after FDA partial hold on epilepsy trial

Recent news mentioning BHVN

• 2026-09-11 — Biohaven Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Biohaven (BHVN)
• 2026-09-03 — Biohaven (BHVN) Cashes In On Its Biggest Epilepsy Bet
• 2026-08-14 — Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline?

Appears alongside

• SueWallSt

Browse the full archive →